Monopar Therapeutics
MNPR
$0.60
Share price
-9.38%
Change (1 day)
-30.45%
Change (1 year)
Categories
Monopar Therapeutics (MNPR) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $1.75 M
According to Monopar Therapeutics's latest financial reports the company's total liabilities are $1.75 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Monopar Therapeutics - Total liabilities on balance sheet (from 2017 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $3.13 M | 98.5% |
| 2021-12-31 | $1.58 M | 34.32% |
| 2020-12-31 | $1.17 M | 62.49% |
| 2019-12-31 | $0.72 M | 81.24% |
| 2018-12-31 | $0.39 M | 28.12% |
| 2017-12-31 | $0.31 M | 383.44% |
| 2016-12-31 | $0.06 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | 1,488.66% | 🇺🇸 USA |